Lantheus Holdings, Inc.

5 filings 3 distinct issuers Active 2020-06-23 → 2026-09-23

Track Record

Total filings

2 SCHEDULE 13D/A · 1 SCHEDULE 13D · 1 SCHEDULE 13G · 1 SC

Distinct issuers

60% issuer diversity

Median stake

12.87%

271,046,012 avg shares

AI briefs cached

0/5

intent-classified filings

Filed	Form	Issuer	Stake	Shares
2026-09-23	SCHEDULE 13D/A	Perspective Therapeutics, Inc.CATX	7.70%	8,739,011	view →
2026-09-04	SCHEDULE 13D	Radiopharm Theranostics LimitedRDPTF	20.90%	792,958,513	view →
2026-09-04	SCHEDULE 13D/A	Perspective Therapeutics, Inc.CATX	10.00%	11,440,513	view →
2026-09-04	SCHEDULE 13G	Radiopharm Theranostics LimitedRDPTF	—	—	view →
2020-06-23	SC	PROGENICS PHARMACEUTICALS INC	—	—	view →

Free. We email you when criteria match. One-click unsubscribe in every email.

Custom alerts on filer activity · full feed access · daily intelligence · API. From $49/mo.